Skip to content

Acceptance and Commitment Therapy for Crystal Methamphetamine Use Disorder (ACT for ICE)

Feasibility and Acceptability of Acceptance and Commitment Therapy for Crystal Methamphetamine Use Disorder (ACT for ICE)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000690459
Acronym
ACT for ICE
Enrollment
12
Registered
2025-06-30
Start date
2025-08-01
Completion date
2026-07-31
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The ACT for ICE project uses an Acceptance and Commitment Therapy based intervention called the Recovery and Support Program (RaSP) to support women with a diagnosis of methamphetamine use disorder. The purpose of this study is to look at how well the RaSP program works in alcohol and drug treatment. This will include looking at how many people participate, their scores on some questionnaires, what they liked and did not like about the program, whether they can think more flexibly after completing the program and whether they are using less methamphetamine.

Interventions

The Recovery and Support Program (RaSP) is 45 sessions long, with 3 sessions covered twice per week over 8 weeks. Each session runs for approximately 1-hour comprising of activities, games and breaks. Some topics covered in the intervention include Present Moment Awareness, Acceptance, Defusion, Values, Committed Action and Self-as-Context. Participants receive a participant manual that they will work through and reference throughout the duration of the program. This manual has been designed for

The Recovery and Support Program (RaSP) is 45 sessions long, with 3 sessions covered twice per week over 8 weeks. Each session runs for approximately 1-hour comprising of activities, games and breaks. Some topics covered in the intervention include Present Moment Awareness, Acceptance, Defusion, Values, Committed Action and Self-as-Context. Participants receive a participant manual that they will work through and reference throughout the duration of the program. This manual has been designed for the trial and is not publicly available. The program structure has been adapted for individual delivery in a face to face format. Facilitators will be alcohol and drug clinicians with relevant experience working with individuals using methamphetamine. Adherence to the sessions will be monitored through attendance, participation and engagement.

Sponsors

University of Tasmania
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All participants must be over the age of 18. Meet DSM-5 criteria for primary Methamphetamine Use Disorder, moderate or severe as determined by a member of the research team. Be female, non-binary, or woman-identifying (i.e., trans-women included) Must be deemed to have capacity to provide informed consent and to follow study instructions and procedures (determined by the clinical judgement of program staff and the MOCA). Ability to understand the PICF

Exclusion criteria

If the individual needs acute psychiatric care or has an unstable psychiatric condition (e.g., for suicidality or acute psychosis) that would reasonably prevent them from engaging in and/or benefiting from the intervention. If the individual needs acute care for intoxication or in need of medically supervised detoxification that would reasonably prevent them from engaging in and/or benefiting from the intervention. If the individual has a cognitive impairment that would reasonably prevent them from engaging in and/or benefiting from the intervention

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026